Acorah Software Products - Accounts Production 19.2.450 false true 31 October 2024 1 November 2023 false 1 November 2024 31 October 2025 31 October 2025 08263014 Dr Hemalal Wimalaratna Doctor Miles Humberstone Dr Christopher Kobylecki iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08263014 2024-10-31 08263014 2025-10-31 08263014 2024-11-01 2025-10-31 08263014 frs-core:CurrentFinancialInstruments 2025-10-31 08263014 frs-core:OtherReservesSubtotal 2025-10-31 08263014 frs-core:RetainedEarningsAccumulatedLosses 2025-10-31 08263014 frs-bus:CompanyLimitedByGuarantee 2024-11-01 2025-10-31 08263014 frs-bus:FilletedAccounts 2024-11-01 2025-10-31 08263014 frs-bus:SmallEntities 2024-11-01 2025-10-31 08263014 frs-bus:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 08263014 frs-bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 08263014 frs-bus:Director1 2024-11-01 2025-10-31 08263014 frs-bus:Director2 2024-11-01 2025-10-31 08263014 frs-bus:Director3 2024-11-01 2025-10-31 08263014 frs-countries:EnglandWales 2024-11-01 2025-10-31 08263014 2023-10-31 08263014 2024-10-31 08263014 2023-11-01 2024-10-31 08263014 frs-core:CurrentFinancialInstruments 2024-10-31 08263014 frs-core:OtherReservesSubtotal 2024-10-31 08263014 frs-core:RetainedEarningsAccumulatedLosses 2024-10-31
Registered number: 08263014
The Neurotoxin Network Ltd
Unaudited Financial Statements
For The Year Ended 31 October 2025
AS Taxation Ltd
The Neurotoxin Network Ltd
Contents
Contents

| Page
--- | ---
Balance Sheet | 1
Notes to the Financial Statements | 2

Page 1
The Neurotoxin Network Ltd
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 08263014

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Cash at bank and in hand |  | 58,555 |  | 70,983 |
|  | 58,555 |  | 70,983 |
Creditors: Amounts Falling Due Within One Year | 4 | (2,341 ) |  | (1,141 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 56,214 |  | 69,842
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 56,214 |  | 69,842
NET ASSETS |  |  | 56,214 |  | 69,842
RESERVES
Other reserves |  |  | 100,773 |  | 100,773
Income and Expenditure Account |  |  | (44,559 ) |  | (30,931 )
MEMBERS' FUNDS |  |  | 56,214 |  | 69,842

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Income and Expenditure Account.
On behalf of the board

Doctor Miles Humberstone Director
29/05/2026

The notes on page 2 form part of these financial statements.
Page 1
Page 2
The Neurotoxin Network Ltd
Notes to the Financial Statements
For The Year Ended 31 October 2025
Notes to the Financial Statements
1. General Information
The Neurotoxin Network Ltd is a private company, limited by guarantee, incorporated in England & Wales, registered number 08263014 . The registered office is Rock House , Rowen , Conwy , United Kingdom , LL32 8YW.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: )
- -
4. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 2,316 |  | 1,116
Taxation and social security | 25 |  | 25
| 2,341 |  | 1,141

5. Company limited by guarantee
The company is limited by guarantee and has no share capital.
Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1.
Page 2